Your browser doesn't support javascript.
loading
Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation.
Alabsawy, Eman; Sheikh, Mohammed Faisal; Ballester, Maria Pilar; Acharya, Subrat Kumar; Agarwal, Banwari; Jalan, Rajiv.
Afiliación
  • Alabsawy E; Liver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.
  • Shalimar; Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • Sheikh MF; Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
  • Ballester MP; Liver Failure Group, Institute for Liver and Digestive Health, University College London, London, UK.
  • Acharya SK; Digestive Disease Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Agarwal B; INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Jalan R; Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Aliment Pharmacol Ther ; 55(6): 722-732, 2022 03.
Article en En | MEDLINE | ID: mdl-35106777
BACKGROUND: The occurrence of overt hepatic encephalopathy (OHE) is associated with increased mortality. HE is commonly precipitated by infection, but whether HE predisposes to new infection is unclear. This study aimed to test if OHE predisposes to de novo infection during hospitalisation and its association with short-term mortality. AIMS AND METHODS: Seven hundred and fifty-nine consecutive patients were identified at two institutions from prospectively maintained clinical databases of cirrhotic patients admitted with acute decompensation (AD). Infection and HE data were collected on the day of admission, and the occurrence of de novo infections was assessed for 28 days after admission. EASL-CLIF organ failure criteria were used to determine the presence of organ failures. Multivariable analysis using the logistic regression model was used to assess predictors of 28-day mortality and de novo infection. RESULTS: Patients were divided into four groups; no baseline OHE or infection (n = 352); OHE with no baseline Infection (n = 221); no OHE but baseline infection (n = 100) and OHE with baseline infection (n = 86). On multivariate analyses, OHE (OR, 1.532 [95% CI, 1.061-2.300, P = 0.024]), and admission to ITU (OR, 2.303 [95% CI, 1.508-3.517, P < 0.001]) were independent risk factors for de novo infection. 28-day mortality was 25.3%, 60.2%, 55.0% and 72.1% in the 4-groups respectively. Age, INR and creatinine were independently predictive of mortality. The presence of overt HE, infection, coagulation, kidney, circulatory, respiratory and liver failures were significantly associated with higher mortality. CONCLUSION: OHE is an independent risk factor for de novo infection in cirrhotic patients with AD.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encefalopatía Hepática Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encefalopatía Hepática Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido